Brief: Inozyme Pharma Secures Flexible Debt Facility For Up To $70 Million With K2 Healthventures

Inozyme Pharma

26/07/2022 12:44

July 26 (Reuters) - Inozyme Pharma Inc  INZY.O :
    * INOZYME PHARMA SECURES FLEXIBLE DEBT FACILITY FOR UP TO
$70
MILLION WITH K2 HEALTHVENTURES
    * INOZYME PHARMA - EXPECTS CASH, CASH EQUIVALENTS AND
SHORT-TERM
INVESTMENTS AS OF MARCH 31 WILL ENABLE CO TO FUND OPERATIONS
INTO Q2 OF 2024

Source text for Eikon:  ID:nGNX4z9xCQ 
Further company coverage:  INZY.O 

 ((Reuters.Briefs@thomsonreuters.com;))